AEON Biopharma names Paul Lee acting chief regulatory officer
AEON Biopharma designates former FDA neuroscience leader Paul Lee, M.D., Ph.D. as acting chief regulatory officer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
AEON Biopharma designates former FDA neuroscience leader Paul Lee, M.D., Ph.D. as acting chief regulatory officer.